Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Recticel Proxy Solicitation & Information Statement 2017

Apr 28, 2017

3993_rns_2017-04-28_7e903562-d067-445d-b130-d53101b1c6d2.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

V O T I N G F O R M
--------------------- --
The undersigned (for private individuals: surname, first name, occupation and place of
residence; for legal entities: company name, company type, registered office and identity and
position of the representative(s) - see instruction 1 below)
Owner of ordinary shares in public limited company RECTICEL, with its
registered office Avenue des Olympiades/Olympiadenlaan 2, 1140 Brussels (Evere),
am, hereby states that he/she/it wishes to participate in the Ordinary General Meeting of the
above-mentioned Company, which shall take place at the Company's registered office Avenue
des Olympiades/Olympiadenlaan 2 in 1140 Brussels (Evere), on Tuesday May 30, 2017 at 10
wishes to use the possibility to vote by correspondence before the General Meeting for the
above-mentioned number of shares adequately registered on the Registration Date, as
mentioned in the notice convening the General Meeting,
and wishes to enforce the following irrevocable voting instructions (see instruction 2 below):
Voting instructions on the
agenda for the Ordinary General Meeting
1. Examination of the company's consolidated and statutory annual report prepared by the
Board of Directors on the financial year ended 31 December 2016.
2. Examination of the consolidated and statutory annual Auditor's report on the financial
year ended 31 December 2016.
3. Proposals forming the subject of the first resolution:
Examination of the consolidated accounts as on 31 December 2016.
Resolution No 1.1. : Approval of the statutory annual accounts as on 31 December
2016.
FOR:
AGAINST :
ABSTAIN :

{1}------------------------------------------------

Profit for the financial year:
Profit brought forward from the previous year:
Result to be appropriated:
Gross dividend on shares ():
Transfer to legal reserve
Profit to be carried forward:
(
) Gross dividend per share of € 0.18, giving an entitlement to a dividend net of
+
€ 25,005,896.21
+
€ 39,572,274.79
=
€ 64,578,171.00
-
€ 9,731,253.60
-
€ 1,250,294.81
=
€ 53,596,622.59
withholding tax of € 0.126 per ordinary share.
FOR: AGAINST : ABSTAIN :
4. Proposal forming the subject of the second resolution:
Discharge to be given to the Directors for the performance of their duties during the
financial year ended 31 December 2016.
FOR: AGAINST : ABSTAIN :
5. Proposal forming the subject of the third resolution:
Discharge to be given to the Auditor for the performance of his duties during the
financial year ended 31 December 2016.
FOR: AGAINST : ABSTAIN :
6. Proposals forming the subject of the fourth resolution:
Resolution No 4.1. : Notification that the mandate of REVAM BVBA, represented by Mr.
Wilfried Vandepoel, as non-executive director, will end after the Ordinary General
Meeting of 30 May 2017. It is not available for a renewal of the mandate.
Decision is to foresee a replacement.
FOR: AGAINST : ABSTAIN :
Resolution No 4.2. : In replacement of REVAM BVBA, represented by Mr. Wilfried
Vandepoel, appointment of IPGM Consulting GmbH, represented by Ms. Anne De Vos,
as non-executive and independent director, for a term of three years expiring after the
Ordinary General Meeting of 2020.
FOR: AGAINST : ABSTAIN :

Resolution No 1.2. : Approval of the appropriation of the result, i.e.:

{2}------------------------------------------------

Committee at € 5,000 per meeting.
FOR:
Remuneration and Nomination Committee at € 5,000 per meeting.
AGAINST : Resolution No 6.3. : Fixing of the amount of fees for the members of the Audit
Committee for 2017 at € 2,500 per meeting and for the Chairman of the Audit
ABSTAIN :
Resolution No 6.4. : Fixing of the amount of fees for the members of the Remuneration
and Nomination Committee for 2017 at € 2,500 per meeting and for the Chairman of the
FOR: AGAINST : ABSTAIN :


Directors of € 5,000 per meeting.
the Board of Directors of € 30,000 a year; Resolution No 6.2. : Fixing and approval of the Directors' emoluments for 2017, i.e.:
A single fixed indemnity for Directors of € 15,000 a year and for the Chairman of
Directors' fees of € 2,500 per meeting and for the Chairman of the Board of
FOR: AGAINST : ABSTAIN :
corporate governance statement.
Resolution No 6.1. : Approval of the remuneration report.
8. Proposals forming the subject of the sixth resolution: Examination of the remuneration report for financial year 2016, as referred to in the
FOR: AGAINST : ABSTAIN :
Corporation. Ms. Anne De Vos obtained an MBA in international marketing and a Master in Chemical
Engineering and gained experience amongst others with Givaudan and Sigma Aldrich
independence criteria of the Code on Corporate Governance 2009. meets all the criteria indicated in article 526ter of the Companies Code as well as the

{3}------------------------------------------------

In respect of the provisions laid down under Article 520ter of the Companies Code concerning variable remuneration for the members of the Management Committee and the need to defer variable remuneration payments over a three year period in case certain thresholds are passed, the Board of Directors states the following:

  • The principle of a deferral over a three year period of variable remuneration payment would only be applicable to the Managing Director and CEO, Olivier Chapelle SPRL, as all other members of the Management Committee remain below the 25% threshold ;
  • The Remuneration Committee and the Board of Directors reviewed the situation again and decided that it would remain in the best interest of the company to keep the variable remuneration payment structure at the same level for all Management Committee members;

Taking the above into consideration and as the target variable remuneration bonus payout for the Managing Director and CEO surpasses the 25% maximum threshold, , the Board of Directors proposes to the General Shareholders' meeting to approve the said deviation from the principle of a deferral over three years, and hence to allow the full payment of the variable remuneration within one year.

Resolution No 6.5. : Approval of the deviation from the principle of a deferral over three years to allow, for the benefit of the Managing Director and CEO, Olivier Chapelle SPRL, the full payment of the variable remuneration within one year.

FOR:
AGAINST :
ABSTAIN :
-------------------------------- -- -- -- --
  1. Proposal forming the subject of the seventh resolution: New edition of the Stock Option Plan of the Recticel Group.

The Board of Directors intends to issue in the course of the period until the next Ordinary General Meeting of May 2018, within the framework of the authorised capital, a new edition of the Stock Option Plan of the Recticel Group. To this effect, it requests the authorisation of the General Meeting, not through any legal obligation but in accordance with the 2009 Code of Corporate Governance.

The Meeting is requested to give its authorisation to the Board of Directors so that, if appropriate, it can issue a new edition of the Stock Option Plan of the Recticel Group in favour of the senior managers of the Recticel Group. If the Board of Directors decides to do this, the new edition will include the issue of a maximum of 500,000 stock options, with a period for exercising the option of three to maximum nine years and an unavailability period of three years, to be allocated to the beneficiaries free of charge. The issue price will be fixed on the basis of the average price of a Recticel share over the normal period preceding the offer.

* * * *

{4}------------------------------------------------

Name and surname :
Function:
Place and date :
Signature :

RELEVANT INSTRUCTIONS

(1) In order to attend or to be represented at the General Meeting shareholders must present proof of their identity (identity card or passport) and representatives of legal entities must, in addition, provide proof of their power of representation (relevant legal company documents).

Copies of the relevant proof must be attached to this form.

The Company must receive the voting form no later than 24 May 2017. The signed original form, together with the relevant proof, must be handed to the members of bureau no later than the day of the General Meeting.

In the absence of the original form and relevant proof at the General Meeting, the voting form is made null and void.

(2) A vote by correspondence is final.

A lack of voting choices is regarded as abstention.

If shareholders exercise their right under the legal and statutory provisions to submit new motions for resolutions regarding the items on the agenda, the votes by correspondence submitted before the publication of the updated agenda remain valid for the unchanged agenda items included in the current form. Votes on agenda items for which new motions for resolutions have been submitted, shall be considered as abstentions if there is no new vote.

In this case, shareholders can vote by correspondence on these new motions for resolutions by using the updated voting by correspondence form that the Company shall make available.

If shareholders exercise their right under the legal and statutory provisions to put new items on the agenda of the General Meeting, shareholders can vote by correspondence on these new agenda items by using the updated voting by correspondence form that the Company shall make available in that case. The votes included in the current form on existing and unchanged agenda items shall remain valid. If no vote is cast on the new agenda items, this is considered as abstention.

* * * * *